Alkermes (ALKS) Tops Q4 EPS by 13c
Tweet
Share
E-mail
Get Alerts ALKS Hot Sheet
Price: $46.10 -1.66%
EPS Growth %: -108.2%
Financial Fact:
Total revenues: 38.5M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -108.2%
Financial Fact:
Total revenues: 38.5M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q4 EPS of $0.24, $0.13 better than the analyst estimate of $0.11. Revenue for the quarter came in at $324.5 million versus the consensus estimate of $308.88 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
- Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
